Top Pharmaceuticals companies in Netherlands by Total Non-Current Liabilities

This ranking features the top 12 Pharmaceuticals companies in Netherlands ranked by Total Non-Current Liabilities, totalling a Total Non-Current Liabilities of USD 14.05 B, for January 15, 2025.
#
Name
Total Non-Current Liabilities
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 10.00 B
Dec. 31, 2023 USD 24.98 -2.69%

Netherlands

2
USD 1.60 B
Dec. 31, 2023 USD 139.49 1.47%

Netherlands

3
USD 1.23 B
Dec. 31, 2023 USD 45.57 -0.94%

Netherlands

4
USD 550.34 M
Dec. 31, 2023 USD 13.23 -4.06%

Netherlands

5
USD 336.26 M
Dec. 31, 2023 USD 121.51 5.06%

Netherlands

6
USD 166.10 M
Dec. 31, 2023 USD 9.93 5.98%

Netherlands

7
USD 68.75 M
Dec. 31, 2023 USD 2.26 -0.44%

Netherlands

8
USD 35.59 M
Dec. 31, 2023 USD 0.98 -1.01%

Netherlands

9
USD 30.06 M
Dec. 31, 2023 USD 39.01 -3.56%

Netherlands

10
USD 21.96 M
Dec. 31, 2023 USD 673.61 1.66%

Netherlands

11
USD 8.81 M
Dec. 31, 2023 USD 23.67 -3.70%

Netherlands

12
USD 48.08 K
Dec. 31, 2023 USD 16.00 -2.50%

Netherlands

Frequently Asked Questions
  • Which Pharmaceuticals company in Netherlands has the highest Total Non-Current Liabilities ?

    The Pharmaceuticals company in Netherlands with the highest Total Non-Current Liabilities is Koninklijke Philips N.V. (Amsterdam Stock Exchange: PHIA.AS) at USD 10.00 B.

  • Which Pharmaceuticals company in Netherlands has the lowest Total Non-Current Liabilities ?

    The Pharmaceuticals company in Netherlands with the lowest Total Non-Current Liabilities is Pharvaris N.V. (NasdaqGS: PHVS) at USD 48.08 K.